FATE THERAPEUTICS INC Uncategorized Contracts & Agreements
18 Contracts & Agreements
- Description of Securities (Filed With SEC on November 8, 2023)
- Letter Agreement, dated November 7, 2022, by and between Fate Therapeutics, Inc. and Ono Pharmaceutical Co., Ltd (Filed With SEC on November 7, 2022)
- Open Market Sale AgreementSM dated November 4, 2021 by and between Fate Therapeutics, Inc. and Jefferies LLC (Filed With SEC on November 4, 2021)
- Letter Agreement, dated December 4, 2020, by and between the Registrant and Ono Pharmaceutical Co., Ltd (Filed With SEC on February 24, 2021)
- Fate Therapeutics, Inc. Amended and Restated Inducement Equity Plan (Filed With SEC on February 24, 2021)
- Description of Securities (Filed With SEC on February 24, 2021)
- Offer Letter between the Company and Edward J. Dulac III, dated as of May 20, 2020 (Filed With SEC on August 19, 2020)
- Fate Therapeutics, Inc. Inducement Equity Plan (Filed With SEC on March 2, 2020)
- Description of Securities (Filed With SEC on March 2, 2020)
- Offer Letter by and between the Registrant and Bahram Valamehr, dated November 23, 2009 (Filed With SEC on March 5, 2019)
- Offer Letter by and between the Registrant and Cindy R. Tahl, dated October 23, 2009 (Filed With SEC on March 5, 2019)
- Fate Therapeutics, Inc. Inducement Equity Plan (Filed With SEC on March 5, 2019)
- Fate Therapeutics, Inc. Inducement Equity Plan (Filed With SEC on March 5, 2018)
- FATE THERAPEUTICS, INC. FORM OF [DIRECTOR][OFFICER] INDEMNIFICATIONAGREEMENT (Filed With SEC on August 29, 2013)
- Additional abbreviations may also be used though not in the above list. (Filed With SEC on August 29, 2013)
- Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego, CA 92121 (Filed With SEC on August 14, 2013)
- Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego, CA 92121 (Filed With SEC on August 14, 2013)
- FATE THERAPEUTICS, INC. (Filed With SEC on August 14, 2013)
